Literature DB >> 11170347

Human BRCA1 gene rescues the embryonic lethality of Brca1 mutant mice.

J Chandler1, P Hohenstein, D A Swing, L Tessarollo, S K Sharan.   

Abstract

Half of all familial breast cancers are due to mutation in the BRCA1 gene. However, despite its importance, attempts to model BRCA1-induced disease in the mouse have been disappointing. Heterozygous Brca1 knockout mice do not develop mammary tumors and homozygous knockout mice die during embryogenesis from ill-defined causes. Sequence analysis has shown that the coding region, genomic organization, and regulatory sequences of the human and mouse genes are not well conserved. This has raised the question of whether the mouse can serve as an effective model for functional analysis of the human BRCA1 gene. To address this question we have introduced a bacterial artificial chromosome containing the human BRCA1 gene into the germline of Brca1 knockout mice. Surprisingly, we have found that the embryonic lethality of Brca1 knockout mice is rescued by the human transgene. We also show that expression of human BRCA1 transgene mirrors the endogenous murine gene. Our "humanized" transgenic mice can serve as a model system for functional analyses of the human BRCA1 gene. Published 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11170347     DOI: 10.1002/1526-968x(200102)29:2<72::aid-gene1007>3.0.co;2-b

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  15 in total

1.  A simple two-step, 'hit and fix' method to generate subtle mutations in BACs using short denatured PCR fragments.

Authors:  Yongping Yang; Shyam K Sharan
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

Review 2.  Mouse models of inherited cancer syndromes.

Authors:  Sohail Jahid; Steven Lipkin
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

3.  BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling.

Authors:  Sachin Verma; Narayana Yeddula; Yasushi Soda; Quan Zhu; Gerald Pao; James Moresco; Jolene K Diedrich; Audrey Hong; Steve Plouffe; Toshiro Moroishi; Kun-Liang Guan; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-27       Impact factor: 11.205

4.  Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog.

Authors:  Nitish R Mahapatra; Daniel T O'Connor; Sucheta M Vaingankar; Amiya P Sinha Hikim; Manjula Mahata; Saugata Ray; Eugenie Staite; Hongjiang Wu; Yusu Gu; Nancy Dalton; Brian P Kennedy; Michael G Ziegler; John Ross; Sushil K Mahata
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

5.  Long human CHGA flanking chromosome 14 sequence required for optimal BAC transgenic "rescue" of disease phenotypes in the mouse Chga knockout.

Authors:  Sucheta M Vaingankar; Ying Li; Angelo Corti; Nilima Biswas; Jiaur Gayen; Daniel T O'Connor; Sushil K Mahata
Journal:  Physiol Genomics       Date:  2009-12-15       Impact factor: 3.107

6.  Breast cancer gene variants: separating the harmful from the harmless.

Authors:  Susan M Domchek; Roger A Greenberg
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

7.  Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations.

Authors:  Suhwan Chang; Kajal Biswas; Betty K Martin; Stacey Stauffer; Shyam K Sharan
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

8.  Large family with both parents affected by distinct BRCA1 mutations: implications for genetic testing.

Authors:  Anna P Sokolenko; Dmitry A Voskresenskiy; Aglaya G Iyevleva; Elena M Bit-Sava; Nadezhda I Gutkina; Maxim S Anisimenko; Nathalia Yu Sherina; Nathalia V Mitiushkina; Yulia M Ulibina; Olga S Yatsuk; Olga A Zaitseva; Evgeny N Suspitsin; Alexandr V Togo; Valery A Pospelov; Sergey P Kovalenko; Vladimir F Semiglazov; Evgeny N Imyanitov
Journal:  Hered Cancer Clin Pract       Date:  2009-01-26       Impact factor: 2.857

Review 9.  Preclinical mouse models for BRCA1-associated breast cancer.

Authors:  R M Drost; J Jonkers
Journal:  Br J Cancer       Date:  2009-09-29       Impact factor: 7.640

10.  BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A.

Authors:  Julian Puppe; Rinske Drost; Xiaoling Liu; Simon A Joosse; Bastiaan Evers; Paulien Cornelissen-Steijger; Petra Nederlof; Qiang Yu; Jos Jonkers; Maarten van Lohuizen; Alexandra M Pietersen
Journal:  Breast Cancer Res       Date:  2009-08-26       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.